|
TNYA | Tenaya Therapeutics, Inc. |
|
|
TNYA | Tenaya Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 1.05 |
| Leverage | 21.06% |
| Market Cap | $ 79.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -94.1m |
| Margin | -314654.65% |
None